SCHEMBL19283449

SCHEMBL19283449

CC(C)(C)[Si](C)(C)O[C@H]1CC(=O)c2ccccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 2/20 0.35
AR P10275 2/20 0.35
HSD11B1 P28845 1/20 0.35
AKR1C3 P42330 1/20 0.35
BUB1 O43683 1/20 0.34
HTR2C P28335 3/20 0.34
MAOB P27338 3/20 0.33
KDM4E B2RXH2 3/20 0.33
CYP19A1 P11511 3/20 0.33
MAPT P10636 2/20 0.33
HSD17B10 Q99714 2/20 0.33
GLS O94925 1/20 0.33
S100A4 P26447 1/20 0.33
BCHE P06276 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
P2RX7 Q99572 1/20 0.33
ALDH1A1 P00352 2/20 0.33
GAA P10253 1/20 0.32
ALOX15 P16050 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19283591 1.00 ADORA3 (0.35) ADORA3ARHSD11B1AKR1C3BUB1
SCHEMBL20508940 1.00 ADORA3 (0.35) ADORA3ARHSD11B1AKR1C3BUB1
SCHEMBL17398693 0.81 CYP19A1 (0.35) MAOBCYP19A1BCHEALDH1A1TOP2A
SCHEMBL7572292 0.80 ACHE (0.36) MAOBCYP19A1
SCHEMBL31660734 0.75 HTR2C (0.42) ADORA3ARHSD11B1AKR1C3HTR2C
SCHEMBL5108272 0.75 HTR2C (0.42) ADORA3ARHSD11B1AKR1C3HTR2C
SCHEMBL19042465 0.73 ALDH1A1 (0.39) ADORA3ARHSD11B1AKR1C3HTR2C
SCHEMBL7172119 0.72 BUB1 (0.39) BUB1NPC1RAB9ATOP2A
SCHEMBL9053440 0.72 ALDH1A1 (0.41) KDM4EMAPTHSD17B10NPC1ALDH1A1
SCHEMBL12237554 0.72 ADORA3 (0.41) ADORA3ARHSD11B1AKR1C3HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180273573-A1 INHIBITORS OF MENAQUINONE BIOSYNTHESIS MEMORIAL SLOAN-KETTERING CANCER CENTER (US) 2018-09-27 US disclosed
EP-3356447-A1 INHIBITORS OF MENAQUINONE BIOSYNTHESIS Memorial Sloan-Kettering Cancer Center (US) 2018-08-08 EP disclosed
WO-2017059411-A9 INHIBITORS OF MENAQUINONE BIOSYNTHESIS MEMORIAL SLOAN-KETTERING CANCER CENTER (US) 2017-08-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180273573-A1 INHIBITORS OF MENAQUINONE BIOSYNTHESIS COASY, SDHA, VKORC1 ADORA3 4463/4885AR 2366/4885HSD11B1 200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.